Insurance - Brokers
Compare Stocks
4 / 10Stock Comparison
RELI vs GOCO vs SLQT vs UNH
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Brokers
Insurance - Brokers
Medical - Healthcare Plans
RELI vs GOCO vs SLQT vs UNH — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Insurance - Brokers | Insurance - Brokers | Insurance - Brokers | Medical - Healthcare Plans |
| Market Cap | $554K | $13M | $201M | $335.60B |
| Revenue (TTM) | $13M | $738M | $1.64B | $449.71B |
| Net Income (TTM) | $-7M | $-199M | $73M | $12.04B |
| Gross Margin | -14.5% | 82.6% | 69.8% | 18.8% |
| Operating Margin | -66.3% | -40.7% | 3.5% | 4.2% |
| Forward P/E | — | — | 85.7x | 20.2x |
| Total Debt | $13M | $528M | $416M | $78.39B |
| Cash & Equiv. | $373K | $41M | $32M | $24.36B |
RELI vs GOCO vs SLQT vs UNH — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 20 | Mar 26 | Return |
|---|---|---|---|
| Reliance Global Gro… (RELI) | 100 | 0.0 | -100.0% |
| GoHealth, Inc. (GOCO) | 100 | 0.5 | -99.5% |
| SelectQuote, Inc. (SLQT) | 100 | 4.8 | -95.2% |
| UnitedHealth Group … (UNH) | 100 | 96.9 | -3.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: RELI vs GOCO vs SLQT vs UNH
Each card shows where this stock fits in a portfolio — not just who wins on paper.
RELI plays a supporting role in this comparison — it may shine differently against other peers.
GOCO lags the leaders in this set but could rank higher in a more targeted comparison.
SLQT is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 15.5%, EPS growth 106.7%, 3Y rev CAGR 26.0%
- Lower volatility, beta 1.96, Low D/E 72.3%, current ratio 1.60x
- Beta 1.96, current ratio 1.60x
- 15.5% revenue growth vs RELI's 2.3%
UNH carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 25 yrs, beta 0.59, yield 2.4%
- 220.6% 10Y total return vs SLQT's -95.8%
- Lower P/E (20.2x vs 85.7x)
- Beta 0.59 vs GOCO's 2.23, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 15.5% revenue growth vs RELI's 2.3% | |
| Value | Lower P/E (20.2x vs 85.7x) | |
| Quality / Margins | Combined ratio 1.0 vs RELI's 1.5 (lower = better underwriting) | |
| Stability / Safety | Beta 0.59 vs GOCO's 2.23, lower leverage | |
| Dividends | 2.4% yield; 25-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | -3.2% vs GOCO's -88.3% | |
| Efficiency (ROA) | 5.7% ROA vs RELI's -41.3%, ROIC 5.3% vs -32.0% |
RELI vs GOCO vs SLQT vs UNH — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
RELI vs GOCO vs SLQT vs UNH — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
UNH leads in 4 of 6 categories
GOCO leads 1 • RELI leads 0 • SLQT leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — SLQT and UNH each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
UNH is the larger business by revenue, generating $449.7B annually — 34287.4x RELI's $13M. SLQT is the more profitable business, keeping 4.5% of every revenue dollar as net income compared to RELI's -53.4%. On growth, SLQT holds the edge at +5.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $13M | $738M | $1.6B | $449.7B |
| EBITDAEarnings before interest/tax | -$7M | -$194M | $63M | $23.2B |
| Net IncomeAfter-tax profit | -$7M | -$199M | $73M | $12.0B |
| Free Cash FlowCash after capex | -$2M | -$78M | -$62M | $19.7B |
| Gross MarginGross profit ÷ Revenue | -14.5% | +82.6% | +69.8% | +18.8% |
| Operating MarginEBIT ÷ Revenue | -66.3% | -40.7% | +3.5% | +4.2% |
| Net MarginNet income ÷ Revenue | -53.4% | -27.0% | +4.5% | +2.7% |
| FCF MarginFCF ÷ Revenue | -18.1% | -10.6% | -3.8% | +4.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | -27.5% | -71.1% | +5.6% | +2.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +70.1% | -30.4% | -114.5% | +0.7% |
Valuation Metrics
GOCO leads this category, winning 4 of 4 comparable metrics.
Valuation Metrics
At 27.9x trailing earnings, UNH trades at a 67% valuation discount to SLQT's 85.7x P/E. On an enterprise value basis, GOCO's 5.1x EV/EBITDA is more attractive than UNH's 16.7x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $553,552 | $13M | $201M | $335.6B |
| Enterprise ValueMkt cap + debt − cash | $13M | $500M | $584M | $389.6B |
| Trailing P/EPrice ÷ TTM EPS | -0.03x | -1.50x | 85.71x | 27.95x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | — | 20.19x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 5.05x | 6.57x | 16.70x |
| Price / SalesMarket cap ÷ Revenue | 0.04x | 0.02x | 0.13x | 0.75x |
| Price / BookPrice ÷ Book value/share | 0.08x | 0.02x | 0.36x | 3.31x |
| Price / FCFMarket cap ÷ FCF | — | — | — | 20.88x |
Profitability & Efficiency
UNH leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
SLQT delivers a 12.2% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-181 for RELI. SLQT carries lower financial leverage with a 0.72x debt-to-equity ratio, signaling a more conservative balance sheet compared to RELI's 4.35x. On the Piotroski fundamental quality scale (0–9), UNH scores 6/9 vs SLQT's 4/9, reflecting solid financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -181.4% | -64.4% | +12.2% | +11.5% |
| ROA (TTM)Return on assets | -41.3% | -15.3% | +5.7% | +3.9% |
| ROICReturn on invested capital | -32.0% | -0.6% | +5.3% | +9.2% |
| ROCEReturn on capital employed | -45.9% | -0.6% | +6.7% | +9.7% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 4 | 4 | 6 |
| Debt / EquityFinancial leverage | 4.35x | 1.15x | 0.72x | 0.77x |
| Net DebtTotal debt minus cash | $13M | $487M | $384M | $54.0B |
| Cash & Equiv.Liquid assets | $372,695 | $41M | $32M | $24.4B |
| Total DebtShort + long-term debt | $13M | $528M | $416M | $78.4B |
| Interest CoverageEBIT ÷ Interest expense | -4.90x | -4.03x | 4.11x | 4.71x |
Total Returns (Dividends Reinvested)
UNH leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in UNH five years ago would be worth $9,743 today (with dividends reinvested), compared to $3 for RELI. Over the past 12 months, UNH leads with a -3.2% total return vs GOCO's -88.3%. The 3-year compound annual growth rate (CAGR) favors SLQT at -7.1% vs RELI's -83.8% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -54.3% | -58.7% | -16.8% | +10.6% |
| 1-Year ReturnPast 12 months | -74.4% | -88.3% | -57.6% | -3.2% |
| 3-Year ReturnCumulative with dividends | -99.6% | -92.3% | -19.7% | -19.9% |
| 5-Year ReturnCumulative with dividends | -100.0% | -99.4% | -96.1% | -2.6% |
| 10-Year ReturnCumulative with dividends | -100.0% | -99.7% | -95.8% | +220.6% |
| CAGR (3Y)Annualised 3-year return | -83.8% | -57.5% | -7.1% | -7.1% |
Risk & Volatility
UNH leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
UNH is the less volatile stock with a 0.59 beta — it tends to amplify market swings less than GOCO's 2.23 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. UNH currently trades 93.5% from its 52-week high vs RELI's 6.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.19x | 2.23x | 1.96x | 0.59x |
| 52-Week HighHighest price in past year | $3.55 | $8.75 | $2.80 | $395.52 |
| 52-Week LowLowest price in past year | $0.15 | $0.99 | $0.56 | $234.60 |
| % of 52W HighCurrent price vs 52-week peak | +6.9% | +11.3% | +40.7% | +93.5% |
| RSI (14)Momentum oscillator 0–100 | 42.9 | 35.0 | 71.7 | 75.9 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 78K | 1.2M | 7.9M |
Analyst Outlook
UNH leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: SLQT as "Hold", UNH as "Buy". Consensus price targets imply 250.9% upside for SLQT (target: $4) vs 4.2% for UNH (target: $385). UNH is the only dividend payer here at 2.35% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | — | Hold | Buy |
| Price TargetConsensus 12-month target | — | — | $4.00 | $385.43 |
| # AnalystsCovering analysts | — | — | 11 | 52 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +2.4% |
| Dividend StreakConsecutive years of raises | 1 | 2 | 1 | 25 |
| Dividend / ShareAnnual DPS | — | — | — | $8.70 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +12.1% | 0.0% | +1.7% |
UNH leads in 4 of 6 categories (Profitability & Efficiency, Total Returns). GOCO leads in 1 (Valuation Metrics). 1 tied.
RELI vs GOCO vs SLQT vs UNH: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is RELI or GOCO or SLQT or UNH a better buy right now?
For growth investors, SelectQuote, Inc.
(SLQT) is the stronger pick with 15. 5% revenue growth year-over-year, versus 2. 3% for Reliance Global Group, Inc. (RELI). UnitedHealth Group Incorporated (UNH) offers the better valuation at 27. 9x trailing P/E (20. 2x forward), making it the more compelling value choice. Analysts rate UnitedHealth Group Incorporated (UNH) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — RELI or GOCO or SLQT or UNH?
On trailing P/E, UnitedHealth Group Incorporated (UNH) is the cheapest at 27.
9x versus SelectQuote, Inc. at 85. 7x.
03Which is the better long-term investment — RELI or GOCO or SLQT or UNH?
Over the past 5 years, UnitedHealth Group Incorporated (UNH) delivered a total return of -2.
6%, compared to -100. 0% for Reliance Global Group, Inc. (RELI). Over 10 years, the gap is even starker: UNH returned +220. 6% versus RELI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — RELI or GOCO or SLQT or UNH?
By beta (market sensitivity over 5 years), UnitedHealth Group Incorporated (UNH) is the lower-risk stock at 0.
59β versus GoHealth, Inc. 's 2. 23β — meaning GOCO is approximately 280% more volatile than UNH relative to the S&P 500. On balance sheet safety, SelectQuote, Inc. (SLQT) carries a lower debt/equity ratio of 72% versus 4% for Reliance Global Group, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — RELI or GOCO or SLQT or UNH?
By revenue growth (latest reported year), SelectQuote, Inc.
(SLQT) is pulling ahead at 15. 5% versus 2. 3% for Reliance Global Group, Inc. (RELI). On earnings-per-share growth, the picture is similar: SelectQuote, Inc. grew EPS 106. 7% year-over-year, compared to -14. 7% for UnitedHealth Group Incorporated. Over a 3-year CAGR, SLQT leads at 26. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — RELI or GOCO or SLQT or UNH?
SelectQuote, Inc.
(SLQT) is the more profitable company, earning 3. 1% net margin versus -64. 5% for Reliance Global Group, Inc. — meaning it keeps 3. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SLQT leads at 4. 5% versus -54. 8% for RELI. At the gross margin level — before operating expenses — GOCO leads at 83. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is RELI or GOCO or SLQT or UNH more undervalued right now?
Analyst consensus price targets imply the most upside for SLQT: 250.
9% to $4. 00.
08Which pays a better dividend — RELI or GOCO or SLQT or UNH?
In this comparison, UNH (2.
4% yield) pays a dividend. RELI, GOCO, SLQT do not pay a meaningful dividend and should not be held primarily for income.
09Is RELI or GOCO or SLQT or UNH better for a retirement portfolio?
For long-horizon retirement investors, UnitedHealth Group Incorporated (UNH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
59), 2. 4% yield, +220. 6% 10Y return). GoHealth, Inc. (GOCO) carries a higher beta of 2. 23 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (UNH: +220. 6%, GOCO: -99. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between RELI and GOCO and SLQT and UNH?
These companies operate in different sectors (RELI (Financial Services) and GOCO (Financial Services) and SLQT (Financial Services) and UNH (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: RELI is a small-cap quality compounder stock; GOCO is a small-cap quality compounder stock; SLQT is a small-cap high-growth stock; UNH is a large-cap quality compounder stock. UNH pays a dividend while RELI, GOCO, SLQT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.